Gastroenterology · 1 Sept 2026 · Letter

Reply.

Spadaccini, Fabbri + 1 more

Abstract ↗AI briefThe abstract is read at the publisher; the brief is JClub's.

The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.

Read the brief in JClub →

Systemic therapy of biliary tract cancer: The road to personalised strategies.
Journal of hepatology · 1 Oct 2026 · Review
Targeted therapies have significantly improved outcomes for specific subgroups of biliary tract cancer, with FGFR2 fusions and IDH1 mutations showing notable response rates.
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42550920
Open in JClub
A Clinical Perspective on Comparative Models of Pancreatic Cyst Surveillance.
Gastroenterology · 1 Oct 2026 · Letter
Read the brief in JClub
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42409338
Open in JClub
Trastuzumab plus nivolumab with gemcitabine and cisplatin as first-line therapy for HER2-positive unresectable biliary tract cancer: a phase 1b/2 trial.
Nature Medicine · 22 Sept 2026 · Journal Article
A HER2-targeted quadruplet regimen achieved a 55% objective response rate in first-line treatment of HER2-positive unresectable biliary tract cancer, showing promising efficacy.
- Open access
Open
Share
Post on X Post on Bluesky Share on LinkedIn
https://jclub.com.au/a/42773210
Open in JClub

Journals this month

All journals →

Moving areas, week to 3 Oct 2026

All research areas →

Read